Resources
Toolkit for New Buprenorphine Prescribers
Clinical Guides and Algorithms
MOC Webinars
Waiver Training and Support
Pain Resources
Hepatitis C Resources
Research Articles
Other Substance Use Resources and Websites
Toolkit for New Buprenorphine Prescribers
Sample Templates
Additional Protocols and Guides
Clinical Guides and Algorithms
Clinical Guides and Algorithms
Manuals and Guidelines
- SAMHSA Medications for Opioid Use Disorder Manual
- BMC OBAT Policy and Procedure Manual
- The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder
- SAMHSA Trauma-Informed Care in Behavioral Health Services
- Telehealth for Opioid Use Disorder Toolkit: Guidance to Support High-Quality Care
MOC Toolkits
Perioperative Buprenorphine Management
MOC Webinars
In the Clinic
- Benzodiazepines
- Beyond the Waiver: Practical Tips for Buprenorphine
- Buprenorphine Management in Patients with Pain
- Drug Screening
- Methamphetamine: New Risks, Current Treatments
- Motivational Interviewing: Affirmations
- Motivational Interviewing Spirit: Connections with Clients
- Tobacco Use Disorder
- Integrating Reproductive and Sexual Health Services in OUD Treatment
- Mood and Anxiety Disorders in Pregnancy and Postpartum
- The Role of Primary Care in Expanding Medication Treatment for Opioid Use Disorder
- Psychostimulants: Cocaine, Amphetamine, and Methamphetamine
- Buprenorphine for Pain Management
- Trauma Informed Care
- HIV PrEP is Easy!
Policy and/or Research
Waiver Training and Support
Pain Resources
Guidelines and Guides
Articles
MOC Pain Webinars
- Buprenorphine Management in Patients with Pain
- Gabapentinoids
- Treatment Gaps for Patients Taking Opioids for Chronic Pain
Hepatitis C Resources
Clinical Resources
Education Resources and Guidelines
State and Federal Reports and Communications
Hepatitis C Webinars
Research Articles
Diversion
- A Review of Buprenorphine Diversion and Misuse: The Current Evidence Base and Experiences From Around the World
- Addressing misuse and diversion of opioid substitution medication: guidance based on systematic evidence review and real-world experience
- The relationship between diversion-related attitudes and sharing and selling buprenorphine
Emergency Department
- Cost Effectiveness of Emergency Department-Initiated Treatment for Opioid Dependence
- Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization
- Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence
- Emergency department-based peer support for opioid use disorder: Emergent functions and forms
- Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention
- Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program
- One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose
Finance
Hospital
Length of Treatment
MOUD Effectiveness
- Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder
- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Review)
- Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality
- Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995–2009
- Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids
Polysubstance
Pregnancy
- Does Maternal Buprenorphine Dose Affect Severity or Incidence of Neonatal Abstinence Syndrome?
- Naloxone and Metabolites Quantification in Cord Blood of Prenatally Exposed Newborns and Correlations with Maternal Concentrations
- Simultaneous quantification of buprenorphine, naloxone and phase Iand II metabolites in plasma and breastmilk by liquid chromatography–tandem mass spectrometry
Primary Care
- Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study
- A buprenorphine education and training program for primary care residents: Implementation and evaluation
- Collaborative Care of Opioid-Addicted Patients in Primary Care Using Buprenorphine
- Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization
- Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers
Stigma
- Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms
- Does Our Choice of Substance-Related Terms Influence Perceptions of Treatment Need? An Empirical Investigation with Two Commonly Used Terms
- Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation
- Caring for Ms. L. — Overcoming My Fear of Treating Opioid Use Disorder
- Stigma as a fundamental hindrance to the United States opioid overdose crisis response
- Next Stage in Buprenorphine Treatment(Addresses misconceptions about MOUD)
- Interpreting Urine Drug Screen (UDS)
Other Substance Use Resources and Websites
Other substance use disorder treatment organizations and resources
- American Society of Addiction Medicine (ASAM)
- Boston Medical Center (BMC) Office Based Addiction Treatment (OBAT)
- Provider Clinical Support System (PCSS)
- American Association for the Treatment of Opioid Dependence, Inc. (AATOD)
- Harm Reduction Approach to Treatment of All Substance Use Disorders
- National Harm Reduction Coalition